Opendata, web and dolomites

EPICAN SIGNED

Inhibiting tumor cell plasticity by targeting the epigenome in breast cancer

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 EPICAN project word cloud

Explore the words cloud of the EPICAN project. It provides you a very rough idea of what is the project "EPICAN" about.

mostly    epigenetic    single    mechanisms    mammary    mediated    spatio    activation    temporal    validate    epigenome    committed    demonstrated    oncogene    underlying    fate    participate    paramount    hurdle    reactivates    lineage    pik3ca    clinical    unknown    kinase    akt    ill    mutations    cell    regulate    anti    regulators    histological    tumors    alterations    block    disease    cells    epithelial    plasticity    cancers    demonstrates    reprograms    breast    genetic    expression    overarching    activating    mutant    phosphoinositide    outgrowth    tracing    pi3k    oncogenic    progenitors    classified    70    signaling    transformation    subgroups    malignancy    kinases    mice    synergize    reduce    downstream    inhibitors    hypothesize    situ    heterogeneous    regulation    microenvironment    tumor    h1047r    combined    conditional    cancer    hyperactive    presenting    outcomes    resistance    heterogeneity    diversity    inhibition    interactions    multipotent    e545k    therapy    prevent    transgenic    molecular    pik3cah1047r    giving    driver    multipotency   

Project "EPICAN" data sheet

The following table provides information about the project.

Coordinator
UNIVERSITAT BASEL 

Organization address
address: PETERSPLATZ 1
city: BASEL
postcode: 4051
website: www.unibas.ch

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Switzerland [CH]
 Total cost 191˙149 €
 EC max contribution 191˙149 € (100%)
 Programme 1. H2020-EU.1.3.2. (Nurturing excellence by means of cross-border and cross-sector mobility)
 Code Call H2020-MSCA-IF-2018
 Funding Scheme MSCA-IF-EF-ST
 Starting year 2020
 Duration (year-month-day) from 2020-05-01   to  2022-04-30

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    UNIVERSITAT BASEL CH (BASEL) coordinator 191˙149.00

Map

 Project objective

Breast cancer is a heterogeneous disease which is classified into different histological and molecular subgroups presenting different clinical outcomes. Also, the diversity of genetic/epigenetic alterations in cancer cells and their interactions with the microenvironment enhance cell plasticity and result in intra-tumor heterogeneity. While tumor heterogeneity is a major hurdle to anti-cancer therapy, its underlying molecular mechanisms remain ill-defined. The Phosphoinositide 3-kinase (PI3K) pathway, which is hyperactive in more than 70% of breast cancers mostly due to oncogenic activating mutations (PIK3CA-E545K & PIK3CA-H1047R), is a major driver of cell transformation. Using spatio-temporal conditional expression of the mutant PIK3CAH1047R combined with in situ lineage tracing in transgenic mice, recent studies demonstrated that the PIK3CA-H1047R oncogene reprograms lineage-committed mammary epithelial progenitors into a multipotent state, giving rise to heterogeneous mammary tumors. However, the mechanisms by which the PIK3CA-H1047R oncogene reactivates multipotency in breast cancer remain unknown. An increasing number of studies demonstrates that epigenetic regulators participate downstream of PI3K/AKT kinases to regulate the epigenome and contribute to tumor malignancy. Given the importance of epigenetic regulation for cell fate, I hypothesize that the effects of PIK3CA-H1047R signaling on tumor cell plasticity are mediated by epigenetic regulators. Because single inhibition of the PI3K pathway often results in resistance, it is of paramount interest to identify new targets whose inhibition can synergize with PI3K inhibitors to block tumor outgrowth, reduce tumor heterogeneity and prevent resistance. The overarching goal of this proposal is to identify epigenetic regulators downstream of oncogenic activation of the PI3K pathway leading to tumor cell plasticity, and to validate them as new targets in breast cancer.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "EPICAN" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "EPICAN" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.1.3.2.)

MultiSeaSpace (2019)

Developing a unified spatial modelling strategy that accounts for interactions between species at different marine trophic levels, and different types of survey data.

Read More  

E-CLIPS (2019)

Effects of Cross-Linguistic Interactions on Perception of Speech

Read More  

CIGNUS (2019)

CuInGaSe Nanowires Under the Sun

Read More